DataMeds AI, Inc. outlines strategy for FDA's proposed peptide policy
DataMeds AI, Inc. announced its strategy in response to a proposed FDA policy concerning pharmacies preparing certain peptides. The company claims this policy could impact over 6,500 pharmacies. DataMeds AI, Inc. is the sole source for details regarding its strategy and the number of affected pharmacies.
2 articles from 2 outlets covered this story. The underlying claim is sourced from a press release.
What do all outlets agree on?
2 outlets covered “DataMeds AI, Inc. outlines strategy for FDA's proposed peptide policy”. All of them report the following:
- FDA proposed a policy for pharmacies to prepare certain peptides
- DataMeds AI, Inc. is responding to this policy
Which outlets covered this?
All 2 articles found on this story, grouped by the stance of the piece. Every link goes to the original publisher.